The ABCG2 monoclonal antibody with anti-tumor and anti-tumor drug resistance and its use as a new anti-tumor drug are disclosed. A new antigen sequence is also disclosed for inducing the production of monoclonal or polyclonal antibodies against ABCG2. In addition, hybridoma producing monoclonal antibodies against ABCG2 with anti-tumor and anti-drug effects is disclosed.
【技术实现步骤摘要】
【国外来华专利技术】PCT国内申请，说明书已公开。
【技术保护点】
PCT国内申请，权利要求书已公开。
【技术特征摘要】
【国外来华专利技术】2016.09....
还没有人留言评论。发表了对其他浏览者有用的留言会获得科技券。